Shandong Runxin Biotechnology Co., Ltd.（山东润昕生物科技有限公司）is a professional high-tech manufacturer specializing in the research, development, and production of sodium hyaluronate and chondroitin sulfate. Headquartered in Qufu, Shandong Province, China, the company is a trusted global supplier of bioactive raw materials for pharmaceuticals, cosmetics, nutraceuticals, and medical device applications.
Company Background
Established in 2012, Shandong Runxin Biotechnology has quickly positioned itself as a premium supplier in the biotechnology and functional ingredient industry. Leveraging advanced fermentation and purification technologies, the company has built a strong reputation for high-purity, low-endotoxin sodium hyaluronate and pharmaceutical-grade chondroitin sulfate.
Core Business
The core business of Runxin Biotechnology includes the production and global distribution of hyaluronic acid derivatives and glycosaminoglycans for multi-sectoral applications. The company’s vertically integrated production system ensures consistent quality and regulatory compliance across food, cosmetic, and pharmaceutical grades.
Product Offerings
Sodium Hyaluronate:
- Pharmaceutical Grade Sodium Hyaluronate
- Cosmetic Grade Sodium Hyaluronate
- Food Grade Sodium Hyaluronate
- Eye Drop Grade Sodium Hyaluronate
- Hydrolyzed Sodium Hyaluronate
- Injection Grade Sodium Hyaluronate
- Cross-linked Sodium Hyaluronate (for dermal fillers)
- Sodium Acetylated Hyaluronate (long-lasting moisturizing effect)
Chondroitin Sulfate:
- Food Grade Chondroitin Sulfate
- Eye Drop Grade Chondroitin Sulfate
- Injection Grade Chondroitin Sulfate
- Chondroitin Sulfate Solution
All products comply with USP, EP, JP, and Chinese Pharmacopoeia standards and are supported by detailed analytical documentation including COA, MSDS, and third-party test reports.
Specialization and USP
Runxin Biotechnology is distinguished by its:
- Use of microbial fermentation technology for non-animal sourced hyaluronic acid
- Strict quality control with endotoxin levels < 0.05 EU/mg
- Production capacity for multi-molecular weight HA from 3 kDa to 3000 kDa
- Patented process for cross-linking sodium hyaluronate, suitable for medical aesthetic injectables
The company’s sodium hyaluronate is used in over 100 brands of serums, dermal fillers, and functional beverages worldwide.
Financials
While private, industry insights and trade activity suggest:
- Estimated annual revenue: USD 15–20 million
- Export share: Over 70% of total sales
- Strong compound annual growth rate (CAGR) of 20%+ over the past five years
Shipment and Export Records
According to platforms such as ImportYeti and Volza:
- Over 200 recorded export shipments between 2020–2024
- Export destinations: USA, Germany, South Korea, Japan, Brazil
- Top exported products: Pharmaceutical-grade sodium hyaluronate and injection-grade chondroitin sulfate
- Clients include cosmetics manufacturers, injectable filler brands, nutraceutical firms, and pharmaceutical companies
Target Market
Runxin’s products are widely used in:
- Pharmaceuticals: Eye drops, joint injections, wound healing formulations
- Cosmeceuticals: Serums, moisturizers, anti-aging creams, injectable fillers
- Nutraceuticals: Joint health supplements, beauty-from-within drinks
- Medical Devices: Surgical lubricants, adhesion prevention agents
The company offers OEM and private label support, including formulation customization and clinical documentation.
Capabilities
- Annual production capacity:
- Sodium Hyaluronate: Over 300 tons
- Chondroitin Sulfate: Over 200 tons
- GMP-certified production workshops and Class 100,000 cleanroom facilities
- In-house microbiological and chemical testing labs with HPLC, GPC, and UV-Vis systems
- Dual fermentation and extraction lines to meet customized molecular weight specifications
- On-demand formulation support for functional cosmetic and health products
Certifications and Compliance
- ISO 9001:2015 Quality Management System
- ISO 22000 Food Safety Management System
- GMP-compliant facilities for medical-grade production
- Halal and Kosher certified
- Products meet USP, EP, JP, and China Pharmacopoeia standards
- FDA registration for export to the United States
Customer Testimonials
- “Runxin’s low-molecular weight HA has become the cornerstone of our top-selling hydration serum. Exceptional purity and consistency.” – Product Development Head, Cosmetics Brand, South Korea
- “Their injectable-grade sodium hyaluronate performs at par with European standards, making them a valuable partner for our filler line.” – CEO, Medical Aesthetics Company, Germany
Achievements
- Certified as a High-Tech Enterprise in Shandong Province
- Holds 7 invention patents related to HA purification and cross-linking technology
- Supplied raw materials to over 300 international brands
- Participated in China’s national industrial standard development for hyaluronic acid applications
Shandong Runxin Biotechnology Co., Ltd. continues to lead innovation in the hyaluronic acid and chondroitin sulfate sector, offering globally compliant, high-efficacy ingredients trusted across the pharmaceutical, cosmetic, and nutraceutical industries.
